CMM Board
The CMM Board is responsible for the quality of the research performed at CMM. To aid the Board in these matters we also have a Scientific Advisory Board (SAB), consisting of internationally recognized and prominent scientists. The CMM Board normally meets 4-6 times per year.
The CMM Board has the responsibility to ensure that the activities of CMM follow the original intentions as stated by the by-laws of the foundation.
The main task of the CMM Board is to promote thorough and boundary-crossing research within the areas mentioned in the by-laws of the foundation. This includes assuming the utmost responsibility for the continuous evaluation of the CMM activities and that the evaluations lead to concrete actions.
Board of directors
Liselotte Jansson, Chair, Secretary General Alzheimerfonden, Chair of Hypergene AB, Chair of the research foundation AlzeCure. Elected 2011. E-mail: liselotte.jansson@ki.se
Lennart Låftman, MBA DHS, former Chair of Erik Penser Fonder AB, CEO at the now closed 5th Swedish National Pension Fund. Elected 1999.
Ylva Pernow, MD and senior lecturer Department of Molecular Medicine and Surgery, Karolinska Institutet. Representing Karolinska University Hospital. Elected 2015.
Sten Eirik Jacobsen, Professor, Karolinska Institutet and University of Oxford, England. Elected 2015.
Lotta Håkansson, Chair Swedish Rheumatism Association. Elected 2019.
Annika Tibell, Adjunct professor, Karolinska Institutet, Director of Research and Education (FoU) at the Karolinska University Hospital. Elected 2023.
Anders Ahlsson, MD, Healthcare director (Hälso- och sjukvårdsdirektör), Region Stockholm. Elected 2023.
Substitute board members
Magnus Nordenskjöld, Professor, Karolinska Insitutet. Elected 2019
Magnus Thyberg, Head of department Kunskapsutveckling, Region Stockholm. Elected 2019.